Search results
More endpoints met in Insmed’s Phase III brensocatib trial
Clinical Trials Arena· 3 hours agoThe company announced that the ASPEN study met its primary endpoint of reduction in the annualised...
The company announced that the ASPEN study met its primary endpoint of reduction in the annualised...